ADDvise receives order from SHCS on vital signs monitoring solution worth approximately USD 2 million

18-03-2022   Regulatory press release

ADDvise Group AB’s subsidiary Southern Life Systems Inc (“SLS”) has signed a one-year term agreement with Signature Healthcare Consulting Services, LLC (“SHCS”), a group providing personalized medical services in primary care, specialty care and hospital care. The agreement regards an order of Rosie Connectivity Solution, system for vital signs monitoring, in 110 nursing homes in US worth approximately USD 2 million. The installment includes proprietary hardware, software, and disposable medical supplies. Delivery of the order is planned to take place during Q2 2022.

The global vital signs monitor market was valued at USD 7.59 billion in 2020, growing at a CAGR of 7.94%. From 2021 to 2026 the market is expected to reach USD 11.97 billion by 2026. The rise in demand for vital sign monitors is mainly driven by demographic trends such as a growing elderly population.

- I’m pleased to see that we continue to support the healthcare providers in US with SLS system for vital signs monitoring. The underlying long-term demographic trend with more elderly people in need for care drives the demand for our products in this segment, says Rikard Akhtarzand, CEO of ADDvise Group in a comment.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se


Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 18 March 2022 at 15:25 CET.
 

About ADDvise Group
 

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise acquires Seebreath AB

Regulatory

ADDvise Group AB has today entered into a share purchase agreement with the owners of Seebreath AB (“Seebreath”) regarding the acquisition of all the outstanding shares of Seebreath. The acquisition is in line with the letter of intent communicated via a press release dated February 28, 2022. Closing of the acquisition takes place today. Seebreath’s…

Interim report January 1 – March 31 2022

Regulatory

January-March 2022 Net revenue for the period was SEK 162.4 million (87.7), an increase of 85.1 %. Organic growth was 4.2 %. Adjusted EBITDA for the period was SEK 21.3 million (8.0) EBITDA for the period was SEK 21.2 million (8.9) Adjusted profit/loss for the period was SEK 5.8 million (1.6) Basic earnings per share…

ADDvise acquires Surplus Diabetics, Inc.

Regulatory

ADDvise Group AB has today entered into a share purchase agreement with the owners of Surplus Diabetics, Inc. (“Surplus Diabetics”) regarding the acquisition of all the outstanding shares of Surplus Diabetics in accordance with the letter of intent communicated via a press release dated January 17, 2022. Closing of the acquisition takes place today. Surplus…